Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

AbbVie MDD drug Vraylar will have to compete with low-cost aripiprazole and quetiapine generics, says GlobalData

AbbVie has recently submitted a supplementary new drug application (sNDA) to the FDA for Vraylar (cariprazine) as the adjunctive treatment of major depressive disorder (MDD). However, pricey Vraylar will have to compete with low-cost aripiprazole and quetiapine generics, with competition becoming even fiercer when generic brexpiprazole enters the market in 2026, according to GlobalData, a […]
Read more

Decarbonization technologies

Decarbonization technologies are gaining momentum to cut down CO2 emissions from the use of fossil fuels and develop carbon-negative products.  Cleantech 2.0, a new wave of interest in environmental technologies, stresses pursuing more sustainable approaches to save the planet as it grapples with a flurry of critical issues like climate change, mass extinction, and depletion […]
Read more

Russia-Ukraine conflict likely to derail planned M&A deals, says GlobalData

The ongoing Russia-Ukraine conflict is expected to affect the completion of announced or planned cross-border mergers and acquisitions (M&A) deals involving targets based in Russia or Ukraine, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that, 13 cross-border M&A deals involving acquisition targets based in Russia […]
Read more

Novel CAR-T cell approaches of Chinese pharma promote clinical innovation and can address remaining unmet needs, says GlobalData

Chinese pharma companies are continuously focusing on the research and development of new innovative oncology therapies. Recently, Innovent Biologics and Gracell Biotechnologies have initiated Phase I trials for their innovative chimeric-antigen receptor T (CAR-T) therapies. It could further address remaining unmet needs, says GlobalData, a leading data and analytics company. Gracell Biotechnologies’ GC012F is developed […]
Read more

AML treatment landscape in China evolving with availability of multiple precision therapy options, says GlobalData

China has recently approved CStone Pharmaceuticals’ Tibsovo (ivosidenib tablets) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (R/R AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation, providing a new precision therapy for this patient population. With multiple precision therapies now available, the cancer treatment arsenal is expanding for adult acute myeloid leukemia […]
Read more

GlobalData – Internet from Sky: Can LEO Satellites Transform the Future of Connectivity?

Total funding in low earth orbit satellites (LEOs) surpassed $100m in 2021 to support the decline of satellite launch costs, innovative satellite tracking antennas, and ground station equipment to meet the growing satellite internet market demand and provide connectivity in hard-to-access environments. Between 2020 and 2021, total investment in LEO surged by 650%. GlobalData’s recent […]
Read more

Startups promise next wave of web 3.0 transition, finds GlobalData

CEOs and business leaders across industries are eagerly discussing the impact of emerging technologies and innovations such as the development of web 3.0, the third iteration of the Internet. Web 3.0 promises free and transparent flow of digital content and data with privacy and decentralization. Against this backdrop, startups are leading the charge to offer […]
Read more

Industrial Decarbonization

In a world where climate change is increasingly influenced by harmful emissions, decarbonizing the industrial sector becomes the immediate priority to phase out CO2 emanations from the use of fossil fuels.   As countries and companies target net zero emissions by 2050, the term industrial decarbonization gathers momentum as an amalgamation of emerging technologies, advanced materials, […]
Read more

Venture capital investors pour in $6.5bn funding in China startups during January 2022, finds GlobalData

China continues to be the most favorite destination for venture capital (VC) investors across the Asia-Pacific (APAC) region. China startups raised $6.5bn VC funding during January 2022, the highest across the region during the month, reveals GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that a total of […]
Read more
1 … 143 144 145 146 147 … 209